1-deoxynojirimycin has been researched along with Coronary Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, J; Li, Y; Wang, Y; Yu, S; Yu, Z | 1 |
| Alfonso, P; Gervas, J; Giraldo, P; Irun, P; Pocovi, M; Puzo, J | 1 |
| Daida, H; Fukao, K; Fukushima, Y; Hiki, M; Hirose, K; Kiyanagi, T; Kume, A; Kurata, T; Matsumori, R; Miida, T; Miyazaki, T; Ohmura, H; Ohsaka, H; Shimada, K; Sumiyoshi, K | 1 |
3 trial(s) available for 1-deoxynojirimycin and Coronary Disease
| Article | Year |
|---|---|
Mulberry leaf attenuates atherosclerotic lesions in patients with coronary heart disease possibly via 1-Deoxynojirimycin: A placebo-controlled, double-blind clinical trial.
Topics: 1-Deoxynojirimycin; Atherosclerosis; Carotid Intima-Media Thickness; Coronary Disease; Humans; Morus; Plant Leaves | 2021 |
Changes in the atherogenic profile of patients with type 1 Gaucher disease after miglustat therapy.
Topics: 1-Deoxynojirimycin; Adult; Aged; Apolipoprotein A-I; Apolipoproteins B; C-Reactive Protein; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Female; Gaucher Disease; Humans; Lipoprotein(a); Male; Middle Aged; Risk; Triglycerides | 2010 |
Single administration of alpha-glucosidase inhibitors on endothelial function and incretin secretion in diabetic patients with coronary artery disease - Juntendo University trial: effects of miglitol on endothelial vascular reactivity in type 2 diabetic p
Topics: 1-Deoxynojirimycin; Aged; Coronary Artery Disease; Coronary Disease; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Endothelium, Vascular; Enzyme Inhibitors; Female; Glucose; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Incretins; Inositol; Lipid Metabolism; Male; Middle Aged; Treatment Outcome | 2010 |